DiaSorin (DSRLF) Reaches New 52-Week High at $108.36

DiaSorin SpA (OTCMKTS:DSRLF) hit a new 52-week high on Friday . The stock traded as high as $108.36 and last traded at $108.36, with a volume of 2252 shares. The stock had previously closed at $100.10.

TRADEMARK VIOLATION WARNING: “DiaSorin (DSRLF) Reaches New 52-Week High at $108.36” was first reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this story on another site, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The legal version of this story can be viewed at https://www.baseballdailydigest.com/news/2019/05/19/diasorin-dsrlf-reaches-new-52-week-high-at-108-36.html.

DiaSorin Company Profile (OTCMKTS:DSRLF)

DiaSorin S.p.A. develops, produces, and commercializes diagnostic tests in various clinical areas for hospital and private testing laboratories in the market of immunodiagnostics and molecular diagnostics. It offers immunodiagnostics products in the areas of infectious diseases; bone and mineral metabolism; endocrinology, including diabetes, thyroid function, fertility, growth, adrenal function, and gastroenterology; hypertension; oncology; stool diagnostics; autoimmunity; and cardiac and brain damages.

Featured Article: Depreciation

Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.